Special Survey on PD Patients With Renal Dysfunction
Post Marketing Surveillance of BI-Sifrol® (Pramipexole). Special Survey on Patients With Parkinson's Disease and Renal Dysfunction
Sponsor: Boehringer Ingelheim
A observational or N/A phase clinical study on Parkinson Disease, this trial is completed. The trial is conducted by Boehringer Ingelheim and has accumulated 7 data snapshots since 2004. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Feb 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boehringer Ingelheim
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Asahikawa, Japan , Azumino, Japan , Chūō, Japan , Fuji, Japan , Fujinomiya, Japan , Fujisaki, Japan , Fukaya, Japan , Fukui, Japan , Fukuoka, Japan , Gifu, Japan and 87 more locations